Closed

Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - PSA Testing, MRI Reporting and BRCA Digital Decision Resource

NHS England

Value
Not stated
Published
5 Aug 2026
Deadline
26 Aug 2026
Procedure
Not stated
Category
85100000 — Health services; 85145000 — Services provided by medical laboratories; 85148000 — Medical analysis services; 85150000 — Medical imaging services; 72413000 — World wide web (www) site design services; 72212220 — Internet and intranet software development services; 72000000 — IT services: consulting, software development, Internet and support
Location
London, UKI45, SE1 8UG, United Kingdom
Notice reference
074309-2026

Requirements summary

NHS England is running a preliminary market engagement (not a call for competition) for three connected workstreams in its Targeted Prostate Cancer Screening Programme: PSA laboratory processing and pathway support, prostate MRI reporting, and a BRCA digital decision resource/website development and evaluation. The programme targets men at increased risk, including those with a pathogenic or likely pathogenic BRCA2 variant. Workstreams 1 and 2 are expected under the Provider Selection Regime and Workstream 3 under the Procurement Act 2023, subject to approvals. The planned contract period runs from 2026-12-01 to 2029-12-31, and the engagement closes on 2026-08-26.

Key requirements

  • PSA laboratory processing and pathway support for targeted prostate cancer screening
  • Prostate MRI reporting services
  • BRCA digital decision resource / website development and evaluation
  • Input on delivery models, mobilisation requirements, risks, pricing assumptions and pathway interfaces
  • Digital and information governance considerations for the digital resource
  • Suppliers may respond to one, two or all three workstreams; participation is not mandatory for future procurements
  • Indicative contract period 2026-12-01 to 2029-12-31; engagement deadline 2026-08-26

Similar open notices

Preliminary Market Engagement Notice: Targeted Prostate… | ProposAI